PEAK PHARMACEUTICALS, INC. (RMHI) Operating income 2015–2022
PEAK PHARMACEUTICALS, INC. (RMHI) annual operating income history from SEC filings — each fiscal year as reported.
-$163,302FY2022 · since FY2015: -$2.3M → -$163,302
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$163,302 | -137.6% |
| FY2021 | -$68,721 | -1141.6% |
| FY2020 | -$5,535 | +2.6% |
| FY2019 | -$5,684 | +79.6% |
| FY2018 | -$27,823 | +38.2% |
| FY2017 | -$44,987 | -104.1% |
| FY2016 | $1.1M | +146.5% |
| FY2015 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RMHI financial trends
RMHI RevenueRMHI Net incomeRMHI Net marginRMHI Gross profitRMHI Gross marginRMHI Operating marginRMHI Operating cash flowRMHI Free cash flowRMHI Capital expendituresRMHI Return on equityRMHI Stock buybacksRMHI Dividends paidRMHI Total assetsRMHI Total liabilitiesRMHI Shareholders’ equityRMHI overview →